| Mr Jim Clasen, | |
|
401 E Spruce St, Garden City, KS 67846-5679 | |
| (620) 272-2222 | |
| (620) 272-2127 |
| Full Name | Mr Jim Clasen |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 41 Years |
| Location | 401 E Spruce St, Garden City, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174541700 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 54983 (Kansas) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 13-4819-111 035633 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wadley Regional Medical Center | Texarkana, TX | Hospital |
| Baptist St Anthony's Hospital | Amarillo, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| U S Anesthesia Partners Of Texas, Pa | 7315850351 | 2379 |
| Northstar Anesthesia Pa | 7315907128 | 290 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
Isagenix International, a global health and wellness company, ended its annual Celebration 2015 Breakthrough event in San Diego today by raising more than $565,000 for Make-A-Wish® through fundraising and generous Associate and corporate pledges.
Their findings that a chemical imbalance might underlie such damage could also lead to the development of anti-inflammatory drugs without the adverse side effects, the researchers said.
The US Food and Drug Administration has approved a new 'cancer vaccine' for treating men with advanced prostate cancer.
Loneliness - the unpleasant feeling of emptiness or desolation - can creep in and cause suffering to people at any age. But it can be especially debilitating to older adults and may predict serious health problems and even death, according to a new study by UCSF researchers.
› Verified 3 days ago
| Entity Name | U S Anesthesia Partners Of Texas, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548208564 PECOS PAC ID: 7315850351 Enrollment ID: O20031106000563 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
Isagenix International, a global health and wellness company, ended its annual Celebration 2015 Breakthrough event in San Diego today by raising more than $565,000 for Make-A-Wish® through fundraising and generous Associate and corporate pledges.
Their findings that a chemical imbalance might underlie such damage could also lead to the development of anti-inflammatory drugs without the adverse side effects, the researchers said.
The US Food and Drug Administration has approved a new 'cancer vaccine' for treating men with advanced prostate cancer.
Loneliness - the unpleasant feeling of emptiness or desolation - can creep in and cause suffering to people at any age. But it can be especially debilitating to older adults and may predict serious health problems and even death, according to a new study by UCSF researchers.
› Verified 3 days ago
| Entity Name | Northstar Anesthesia Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912978610 PECOS PAC ID: 7315907128 Enrollment ID: O20041015000685 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
Isagenix International, a global health and wellness company, ended its annual Celebration 2015 Breakthrough event in San Diego today by raising more than $565,000 for Make-A-Wish® through fundraising and generous Associate and corporate pledges.
Their findings that a chemical imbalance might underlie such damage could also lead to the development of anti-inflammatory drugs without the adverse side effects, the researchers said.
The US Food and Drug Administration has approved a new 'cancer vaccine' for treating men with advanced prostate cancer.
Loneliness - the unpleasant feeling of emptiness or desolation - can creep in and cause suffering to people at any age. But it can be especially debilitating to older adults and may predict serious health problems and even death, according to a new study by UCSF researchers.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jim Clasen, 3000 W 95th Ave, Hutchinson, KS 67502-9457 Ph: (620) 272-2222 | Mr Jim Clasen, 401 E Spruce St, Garden City, KS 67846-5679 Ph: (620) 272-2222 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
Isagenix International, a global health and wellness company, ended its annual Celebration 2015 Breakthrough event in San Diego today by raising more than $565,000 for Make-A-Wish® through fundraising and generous Associate and corporate pledges.
Their findings that a chemical imbalance might underlie such damage could also lead to the development of anti-inflammatory drugs without the adverse side effects, the researchers said.
The US Food and Drug Administration has approved a new 'cancer vaccine' for treating men with advanced prostate cancer.
Loneliness - the unpleasant feeling of emptiness or desolation - can creep in and cause suffering to people at any age. But it can be especially debilitating to older adults and may predict serious health problems and even death, according to a new study by UCSF researchers.
› Verified 3 days ago
Thomas Scott Troy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 411 N Campus, Garden City, KS 67846 Phone: 620-276-7699 | |
Christopher Friedly, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2222 | |
Chris P Omenski, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2222 Fax: 620-272-2216 | |
John Christian Newcomer, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2222 | |
Lynn Gage Dunford, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 411 N Campus, Garden City, KS 67846 Phone: 620-276-7699 | |
Kamau P Gitau, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3501 N Campus Dr, B204, Garden City, KS 67846 Phone: 208-604-2938 | |
Mr. Brian L Tackitt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2610 |